Substituted pyrazole compounds are angiotensin II antagonists and therefore useful in the treatment of hypertension, and related cardiovascular disorders and ocular hypertension. These compounds have the general formula I: ##STR1##
The design, binding affinity prediction and synthesis of macrocyclic angiotensin II AT1 and AT2 receptor antagonists
作者:Stephen E. de Laszlo、Tomasz W. Glinka、William J. Greenlee、Richard Ball、Robert B. Nachbar、Kristine Prendergast
DOI:10.1016/0960-894x(96)00116-3
日期:1996.4
Analysis of the SAR of AT(1) selective and AT(1)/AT(2) balanced affinity angiotensin II antagonists led to the design of macrocyclic quinazolinone ligands. CoMFA analysis was used to predict the binding affinities of these novel ligands. The synthesis, X-ray crystal structure, binding affinity and the relevance of these studies to the determination of the biologically relevant binding conformation is discussed. Copyright (C) 1996 Elsevier Science Ltd
Substituted triazolinones, triazolinethiones, and triazolinimines as
申请人:Merck & Co., Inc.
公开号:US05411980A1
公开(公告)日:1995-05-02
There are disclosed new substituted triazolinone, triazolinethione, and triazolinimine compounds which are useful as angiotensin II antagonists. These compounds have the general formula: ##STR1## wherein G is R.sup.1 or ##STR2##